C07K 16/4225
Against anti-hiv ig
Official title: {against anti-HIV Ig}
C07K16/4225 (Against anti-hiv ig) appears on 26 US grants and 18 published applications in this corpus.
Search patents in C07K- Granted patents
- 26
- Published applications
- 18
- Assignees
- 21
- Inventors
- 49
- Latest grant
- 16 Mar 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 1 |
| 2002 | 2 | 2 |
| 2003 | 0 | 2 |
| 2004 | 2 | 3 |
| 2005 | 1 | 2 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 1 |
| 2011 | 1 | 0 |
| 2012 | 0 | 1 |
| 2013 | 1 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Consensus/ancestral immunogens16 Mar 2021US 10,946,090 B2Duke University
- Modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins capable of inducing broadly reactive T- and B-cell responses19 Dec 2017US 9,844,589 B2Duke University
- Target of EGR1 (TOE1) polypeptides for inhibition of HIV23 Aug 2016US 9,422,350 B2
- Anti-idiotype monoclonal antibodies mimicking the HIV gp120 CD4-binding (CD4bs)5 Feb 2013US 8,367,061 B2Pomona Ricera S.R.L.
- Nucleic acids encoding modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins6 Dec 2011US 8,071,107 B2Duke University
- Mini bodies as vaccines for hiv23 Jan 2025US 2025/0026857 A1Pomona Ricerca S.r.l.
- Hiv vaccine immunogens1 Feb 2024US 2024/0033341 A1
- Consensus/ancestral immunogens18 Oct 2018US 2018/0296665 A1Duke University
- Method for the induction of an immune response6 Aug 2015US 2015/0216973 A1Network Immunology Inc.
- Target of egr1 (toe1) polypeptides for inhibition of hiv14 Mar 2013US 2013/0065819 A1
Most cited
By later US patents
- Variable heavy and light chain regions of murine monoclonal antibody 1F767US 6,057,421 AImmpheron, Inc. · 2000
- Method for reducing T cell-mediated cytotoxicity in HIV using anti-idiotypic antibody36US 6,146,627 ASidney Kimmel Cancer Center · 2000
- Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates28US 5,866,694 A1999
- Nucleic acids encoding modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins25US 8,071,107 B2Duke University · 2011
- HIV-vaccines15US 5,911,989 APolynum Scientific Immunbiologische Forschung GmbH · 1999